company background image
603233 logo

DaShenLin Pharmaceutical Group XSSC:603233 Stock Report

Last Price


Market Cap







19 Jun, 2024


Company Financials +

DaShenLin Pharmaceutical Group Co., Ltd.

XSSC:603233 Stock Report

Market Cap: CN¥18.5b

DaShenLin Pharmaceutical Group Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DaShenLin Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥16.25
52 Week HighCN¥30.22
52 Week LowCN¥16.23
1 Month Change-28.10%
3 Month Change-25.36%
1 Year Change-41.92%
3 Year Change-54.12%
5 Year Change-23.42%
Change since IPO-6.70%

Recent News & Updates

Recent updates

Shareholder Returns

603233CN Consumer RetailingCN Market

Return vs Industry: 603233 underperformed the CN Consumer Retailing industry which returned -26.3% over the past year.

Return vs Market: 603233 underperformed the CN Market which returned -15.5% over the past year.

Price Volatility

Is 603233's price volatile compared to industry and market?
603233 volatility
603233 Average Weekly Movement5.1%
Consumer Retailing Industry Average Movement6.0%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.1%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 603233's share price has been volatile over the past 3 months.

Volatility Over Time: 603233's weekly volatility (5%) has been stable over the past year.

About the Company


DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

DaShenLin Pharmaceutical Group Co., Ltd. Fundamentals Summary

How do DaShenLin Pharmaceutical Group's earnings and revenue compare to its market cap?
603233 fundamental statistics
Market capCN¥18.51b
Earnings (TTM)CN¥1.07b
Revenue (TTM)CN¥25.34b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603233 income statement (TTM)
Cost of RevenueCN¥16.47b
Gross ProfitCN¥8.86b
Other ExpensesCN¥7.79b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)0.94
Gross Margin34.98%
Net Profit Margin4.22%
Debt/Equity Ratio45.3%

How did 603233 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio

Does 603233 pay a reliable dividends?

See 603233 dividend history and benchmarks
When do you need to buy 603233 by to receive an upcoming dividend?
DaShenLin Pharmaceutical Group dividend dates
Ex Dividend DateJun 21 2024
Dividend Pay DateJun 21 2024
Days until Ex dividend1 day
Days until Dividend pay date1 day

Does 603233 pay a reliable dividends?

See 603233 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.